Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 62,632
  • Shares Outstanding, K 92,665
  • Annual Sales, $ 780 K
  • Annual Income, $ -35,320 K
  • EBIT $ -30 M
  • EBITDA $ -29 M
  • 60-Month Beta 1.17
  • Price/Sales 69.47
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings $-0.07 on 11/14/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 551.99% ( -241.27%)
  • Historical Volatility 113.69%
  • IV Percentile 82%
  • IV Rank 39.56%
  • IV High 1,187.37% on 04/18/24
  • IV Low 136.08% on 10/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,607
  • Open Int (30-Day) 1,550

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +45.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5200 +29.98%
on 12/05/24
0.8400 -19.54%
on 11/22/24
-0.1341 (-16.56%)
since 11/20/24
3-Month
0.5200 +29.98%
on 12/05/24
0.9000 -24.90%
on 10/07/24
+0.0159 (+2.41%)
since 09/20/24
52-Week
0.4301 +57.15%
on 08/09/24
1.2300 -45.05%
on 02/06/24
+0.0158 (+2.39%)
since 12/20/23

Most Recent Stories

More News
US Ambassador Adler visits Belgian Volition

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler, U.S....

VNRX : 0.6759 (+16.33%)
Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has published a report summarising key themes from...

VNRX : 0.6759 (+16.33%)
Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison...

VNRX : 0.6759 (+16.33%)
Volition Hosts Key Opinion Leader Roundtable on Sepsis Management

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is hosting a Key Opinion Leader ("KOL") roundtable...

VNRX : 0.6759 (+16.33%)
VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June...

VNRX : 0.6759 (+16.33%)
VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, August 15 at 8.30 a.m. Eastern...

VNRX : 0.6759 (+16.33%)
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that the underwriters of its...

VNRX : 0.6759 (+16.33%)
VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today the closing of its previously...

VNRX : 0.6759 (+16.33%)
VolitionRx Limited Announces Pricing of $16.5 Million Underwritten Public Offering of Common Stock

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today the pricing of an...

VNRX : 0.6759 (+16.33%)
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it has...

VNRX : 0.6759 (+16.33%)

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

3rd Resistance Point 0.8093
2nd Resistance Point 0.7446
1st Resistance Point 0.7103
Last Price 0.6759
1st Support Level 0.6113
2nd Support Level 0.5466
3rd Support Level 0.5123

See More

52-Week High 1.2300
Fibonacci 61.8% 0.9244
Fibonacci 50% 0.8300
Fibonacci 38.2% 0.7357
Last Price 0.6759
52-Week Low 0.4301

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar